Pharma Cultivation ApS: Financial statements 2020
CVR: 39699370
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
Pharma Cultivation ApS (CVR 39699370) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -39,417 and a net result of DKK -38,557 compared with DKK -5,965 the year before. Equity in the 2020 report amounted to DKK -522.
- Gross Profit
- DKK -39,417
- Profit/Loss
- DKK -38,557
- Equity
- DKK -522
- Total Assets
- DKK 11,091
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -39 t. | -39 t. | -522 | 0 |
| 2019 | - | -7 t. | -6 t. | -6 t. | 0 |
Official annual report
How creditworthy is Pharma Cultivation ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 12, 2020, Lars Goul Nielsen is registered as director of Pharma Cultivation ApS.
As of November 12, 2020, Jesper Aagesen Svensson has stepped down as director of Pharma Cultivation ApS.
About Pharma Cultivation ApS
Pharma Cultivation ApS was a Danish company of the type Anpartsselskab based in Farsø, founded in 2018. The company has been dissolved on 9 April 2026. The company was registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The company was previously named Gistrup Green Grow ApS and Gistrup Green Grow IVS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK 49,311 and a net result of DKK -979,208 compared with DKK -875,540 the year before. Equity in the 2023 report amounted to DKK -2,895,006.